| _version_ | 1866901683190104064 |
|---|---|
| author | Tripdatabase |
| author_facet | Tripdatabase |
| contents | Fosfomycin, often as part of a combination therapy, appears effective against carbapenem-resistant Acinetobacter species, though monotherapy is likely inadequate due to intrinsic resistance. Combination regimens improve clinical outcomes and microbiological eradication. |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_17977466 |
| institution | Zenodo |
| language | |
| publishDate | 2025 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | What is the effectiveness of fosfomycin in treating infections caused by Acinetobacter species? Tripdatabase effectiveness fosfomycin treating infections caused acinetobacter species Fosfomycin, often as part of a combination therapy, appears effective against carbapenem-resistant Acinetobacter species, though monotherapy is likely inadequate due to intrinsic resistance. Combination regimens improve clinical outcomes and microbiological eradication. |
| title | What is the effectiveness of fosfomycin in treating infections caused by Acinetobacter species? |
| topic | effectiveness fosfomycin treating infections caused acinetobacter species |
| url | https://doi.org/10.5281/zenodo.17977466 |